Gene regulatory networks: a new conceptual framework to analyse breast cancer behaviourDEMICHELI, R; CORADINI, D.Annals of oncology. 2011, Vol 22, Num 6, pp 1259-1265, issn 0923-7534, 7 p.Article

A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia : preliminary preclinical resultsCORADINI, D; PELLIZZARO, C; DAIDONE, M. G et al.Leukemia. 2006, Vol 20, Num 5, pp 785-792, issn 0887-6924, 8 p.Article

Time-dependent relevance of steroid receptors in breast cancerCORADINI, D; DAIDONE, M. G; BORACCHI, P et al.Journal of clinical oncology. 2000, Vol 18, Num 14, pp 2702-2709, issn 0732-183XArticle

The effect of ICI 164384 and β-interferon on the growth and steroid receptor profile of breast cancer cell linesCORADINI, D; BIFFI, A; PIRRONELLO, E et al.Anticancer research. 1995, Vol 15, Num 6B, pp 2557-2561, issn 0250-7005Article

Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patientsZAMBETTI, M; BONADONNA, G; VALAGUSSA, P et al.Journal of the National Cancer Institute. Monographs. 1992, Num 11, pp 77-83, issn 1052-6773Article

Estrogen and progesterone receptors in breast cancer : immunohistochemical assay on scraping materialFRIGO, B; PILOTTI, S; CORADINI, D et al.Analytical and quantitative cytology and histology. 1992, Vol 14, Num 2, pp 129-136, issn 0884-6812Article

Biological characterisation of primary and metachronous lesions in breast cancer patientsSILVESTRINI, R; VALENTINIS, B; DAIDONE, M. G et al.European journal of cancer. Part A. 1992, Vol 28, Num 12, pp 2006-2010Article

Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients : An exploratory investigationCORADINI, D; BIGANZOLI, E; BORACCHI, P et al.International journal of cancer. 1998, Vol 79, Num 4, pp 305-311, issn 0020-7136Article

Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?CORADINI, D; ORIANA, S; MARIANI, L et al.European journal of cancer (1990). 1998, Vol 34, Num 6, pp 825-830, issn 0959-8049Article

Simultaneous but not sequential treatment with sodium butyrate improves the antiproliferative effect of α- or β-interferon on a breast cancer cell lineBIFFI, A; CORADINI, D; PELLIZZARO, C et al.Anticancer research. 1998, Vol 18, Num 6A, pp 4109-4114, issn 0250-7005Conference Paper

Combined effect of tamoxifen or interferon-β and 4-hydroxyphenylretinamide on the growth of breast cancer cell linesCORADINI, D; BIFFI, A; PELLIZZARO, C et al.Tumor biology. 1997, Vol 18, Num 1, pp 22-29, issn 1010-4283Article

Interaction between hormone-dependent and hormone-independent human breast cancer cellsCAPPELLETTI, V; RUEDL, C; GRANATA, G et al.European journal of cancer : (1990). 1991, Vol 27, Num 9, pp 1154-1157Article

Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cellsRUEDL, C; CAPPELLETTI, V; CORADINI, D et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 2, pp 195-200, issn 0960-0760, 6 p.Article

An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancerQUERZOLI, P; CORADINI, D; FRASSON, C et al.British journal of cancer. 2010, Vol 103, Num 12, pp 1835-1839, issn 0007-0920, 5 p.Article

Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid deliveryPELLIZZARO, C; CORADINI, D; MOREL, S et al.Anticancer research. 1999, Vol 19, Num 5B, pp 3921-3925, issn 0250-7005Article

Estrogen-receptor status of patients who underwent mastectomy for breast cancer with a disease-free interval of not less than 8 yearsBASSO RICCI, S; CORADINI, D; DI FRONZO, G et al.American journal of clinical oncology. 1998, Vol 21, Num 3, pp 250-252, issn 0277-3732Article

Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamidePELLEGRINI, R; MARIOTTI, A; PIEROTTI, M. A et al.Cell growth and differentiation. 1995, Vol 6, Num 7, pp 863-869, issn 1044-9523Article

Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapySILVERSTRINI, R; DAIDONE, M. G; MASTORE, M et al.Journal of clinical oncology. 1993, Vol 11, Num 6, pp 1150-1155, issn 0732-183XArticle

³H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patientsVALENTINIS, B; SILVESTRINI, R; DAIDONE, M. G et al.Breast cancer research and treatment. 1991, Vol 20, Num 1, pp 19-24, issn 0167-6806Article

A prediction model for breast cancer recurrence after adjuvant hormone therapyBORACCHI, P; CORADINI, D; ANTOLINI, L et al.The International journal of biological markers. 2008, Vol 23, Num 4, pp 199-206, issn 0393-6155, 8 p.Article

Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factorsBIGANZOLI, E; BORACCHI, P; CORADINI, D et al.Annals of oncology. 2003, Vol 14, Num 10, pp 1484-1493, issn 0923-7534, 10 p.Article

Antiproliferative effect of fermented milk on the growth of a human breast cancer cell lineBIFFI, A; CORADINI, D; LARSEN, R et al.Nutrition and cancer. 1997, Vol 28, Num 1, pp 93-99, issn 0163-5581Article

int-2 oncogene amplification and prognosis in node-negative breast carcinomaFIORAVANTI, L; CAPPELLETTI, V; CORADINI, D et al.International journal of cancer. 1997, Vol 74, Num 6, pp 620-624, issn 0020-7136Article

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancerCAPPELLETTI, V; CORADINI, D; SCANZIANI, E et al.European journal of cancer. Part A. 1992, Vol 28, Num 8-9, pp 1315-1318Article

Activity of tamoxifen and its metabolites on endocrine-dependent and endocrine-independent breast cancer cellsCORADINI, D; CAPPELLETTI, V; GRANATA, G et al.Tumor biology. 1991, Vol 12, Num 3, pp 149-158, issn 1010-4283Article